A Multi-Disciplinary Technology-Based Care for Diabetic Ketoacidosis in Patients With Type 1 Diabetes
Key facts
- Who runs it
- The Cleveland Clinic
- Where
- Cleveland, United StatesSee the site
- Trial code
- Status
- Terminated
- People taking part
- 2 people enrolled
- Started
- 15 Nov 2024
- Ended
- 1 Nov 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Continuous Glucose Monitoring (CGM)
- Standard of Care
- Record updated
- 20 February 2026
- Why it stopped
- Recruitment was too difficult - not enough patients were enrolled after 1 year
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Age 18 years old or older
- Diagnosis of Type 1 Diabetes
- Admitted to the hospital with confirmed DKA as determined by emergency department or admitting team
- Compatible smart phone with the Libre 3
- Active insurance plan
Who cannot take part
- Allergy to any component of the Libre 3
- Condition which, in investigator judgement would limit their ability to participate safely
Where in United States
- The Cleveland Clinic FoundationCleveland, United States
About the trial
What the trial wants to find out
The study team proposes that use of a novel multi-disciplinary approach with continuous glucose monitoring technology can significantly improve glycemic control and reduce readmissions among those with type 1 diabetes mellitus (T1DM) admitted for Diabetic ketoacidosis (DKA). This will also help promote a pathway for care of these patients after admission utilizing resources which are available within the Endocrinology, Diabetes and Metabolism department at the Cleveland Clinic.
The 2 groups in the trial
- Control Arm - Standard of Care, retrospectiveOther group
Retrospective data looking at 12 patients undergoing standard of care for diabetic ketoacidosis
Treatment: Standard of Care
- Intervention Arm - Continuous Glucose Monitoring (CGM)Existing treatment, for comparison
12 patients with confirmed diabetic ketoacidosis upon hospital admission will receive continuous glucose monitor (CGM)
Treatment: Continuous Glucose Monitoring (CGM)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Multi-Disciplinary Technology-Based Care After Hospitalization for Diabetic Ketoacidosis in Patients With Type 1 Diabetes
- Record updated
- 20 February 2026